Patents for A01K 67 - Rearing or breeding animals, not otherwise provided for; New breeds of animals (34,042)
11/2002
11/28/2002WO2002094865A1 Nonhuman pregnane x receptor sequences for use in comparative pharmacology
11/28/2002WO2002094863A2 INTERFERON-α INDUCED GENE
11/28/2002WO2002094862A2 Hypoxia inducible factors and uses thereof for inducing angiogenesis and improving muscular functions
11/28/2002WO2002094016A1 Knockin nonhuman animal producing human tissue factor
11/28/2002WO2002074345A3 Immune modulation by transduced hematopoietic stem cells expressing antigens and antigen-presenting cell regulatory molecules
11/28/2002WO2002070563A3 Nuclear hormone receptor ligand binding domain
11/28/2002WO2002035235A3 Net as regulator of angiogenic expression
11/28/2002WO2002034040A3 Method for generating transgenic fish embryos using an episomal vector system
11/28/2002WO2002008442A9 Means and methods for raising antibody concentration in compartments of the body of a non human animal
11/28/2002WO2001096393A9 Nucleotide and amino acid sequences of oocyte factors for altering ovarian follicular growth in vivo or in vitro
11/28/2002WO2001059459A3 Compositions and methods for screening therapeutic agents
11/28/2002US20020178461 Transgenic fish with tissue-specific expression
11/28/2002US20020178460 Animal model for use as tools in genetic engineering
11/28/2002US20020178459 Genetically engineered mammal for use in the treatment of muscle and liver disorders
11/28/2002US20020178458 Compositions and methods for the treatment and diagnosis of cardiovascular disease using rchd534 as a target
11/28/2002US20020178457 Transgenic animals; genetic engineering
11/28/2002US20020178456 Polyclonal antibodies for use inthe treatment and prevention of bacteria, fungi, virus and parasites infections
11/28/2002US20020177564 DNA construct comprising said exogenous gene under the control of an ecdysone response element; and a modified ecdysone receptor which, in the presence of a ligand therefor, binds to said ecdysone response element
11/28/2002CA2448145A1 Engineered secreted alkaline phosphatase (seap) reporter genes and polypeptides
11/28/2002CA2448092A1 Internalisation of virus into cells
11/28/2002CA2447958A1 Hypoxia inducible factors and uses thereof for inducing angiogenesis and improving muscular functions
11/28/2002CA2445972A1 Methods and compositions for treating respiratory mucin production associated disease conditions
11/28/2002CA2441666A1 Phytases, nucleic acids encoding them and methods and using them
11/27/2002EP1260228A2 Human growth gene and short stature gene region. Therapeutic uses
11/27/2002EP1259611A2 G-protein coupled receptors
11/27/2002EP1259609A2 Human schizophrenia gene
11/27/2002EP1259608A1 Modified fluorescent proteins
11/27/2002EP1089619A4 Artificial media for rearing entomophages
11/27/2002EP1019504A4 Isoforms of the human vitamin d receptor
11/27/2002EP0938551A4 Ku DEFICIENT CELLS AND NON-HUMAN TRANSGENIC ANIMALS
11/27/2002CN1382217A Beta-barrel of lipid miniature lipoxidase
11/27/2002CN1382156A PABLO polypeptide that interacts with BCL-XL and uses related thereto
11/26/2002US6486381 Genetically engineered mice containing alterations in the genes encoding retinoic acid receptor proteins
11/26/2002US6486380 Pancreatic β cell hexokinase transgene
11/26/2002US6486299 Genes and proteins predictive and therapeutic for stroke, hypertension, diabetes and obesity
11/26/2002US6485912 Methods of performing gene trapping in bacterial and bacteriophage-derived artificial chromosomes and use thereof
11/26/2002US6485911 Methods for determining risk of developing alzheimer's disease by detecting mutations in the presenilin 2 (PS-2) gene
11/26/2002US6485722 Method for selective engraftment of drug-resistant hematopoietic stem cells
11/26/2002CA2228635C Mammalian apoptosis inhibitor protein gene family, primers, probes and detection methods
11/26/2002CA2100864C Method for delivering direct feed microorganisms to poultry in ovo
11/21/2002WO2002092842A2 Nucleic acids and corresponsing proteins entitled 101p3a11 or phor-1 useful in treatment and detection of cancer
11/21/2002WO2002092841A2 Nucleic acid molecules encoding a transmembrane serine protease 10, the encoded polypeptides and methods based thereon
11/21/2002WO2002092817A1 Functions for d52 and ra006 nucleic acids and polypeptides
11/21/2002WO2002092812A1 ARTIFICIAL HUMAN CHROMOSOME CONTAINING HUMAN ANTIBODY μ LIGHT CHAIN GENE
11/21/2002WO2002092764A2 Transgenic animal model of bone mass modulation
11/21/2002WO2002092758A2 Gastrokines and derived peptides including inhibitors
11/21/2002WO2002092015A2 Reagents and methods for modulating dkk-mediated interactions
11/21/2002WO2002092000A2 Hbm variants that modulate bone mass and lipid levels
11/21/2002WO2002091820A1 Nonhuman model animal of oligodendrocyte development disability
11/21/2002WO2002079447A9 Avian lysozyme promoter
11/21/2002WO2002077211A8 A virus (cryptovirus) within the rubulavirus genus and uses therefor
11/21/2002WO2002057290A3 Novel fibronectin epitopes and proteinaceous molecules capable of binding said epitopes
11/21/2002WO2001034646A9 Recombinant gelatins
11/21/2002US20020174449 Replacing sex chromosome in animals to be cloned; breeding pairs
11/21/2002US20020174446 Identification of genes involved in alzheimer's disease using drosophila melanogaster
11/21/2002CA2447564A1 Nucleic acids and corresponding proteins entitled 101p3a11 or phor-1 useful in treatment and detection of cancer
11/21/2002CA2447050A1 Nucleic acid molecules encoding a transmembrane serine protease 10, the encoded polypeptides and methods based thereon
11/21/2002CA2446859A1 Transgenic animal model of bone mass modulation
11/21/2002CA2446821A1 Hbm variants that modulate bone mass and lipid levels
11/21/2002CA2446582A1 Reagents and methods for modulating dkk-mediated interactions
11/21/2002CA2442635A1 Gastrokines and derived peptides including inhibitors
11/20/2002EP1257814A1 Mouse model for rheumatoid arthritis
11/20/2002EP1257671A1 Nucleic acid molecule encoding a mismatch endonuclease and methods of use thereof
11/20/2002EP1257645A2 Fibroblast growth factor-23 molecules and uses thereof
11/20/2002EP1257635A2 Lipid metabolism enzymes and polynucleotides encoding them
11/20/2002EP1257633A1 Presenilin deficient multipotent cell lines and screening methods for intramembrane regulated proteolytic activities using these lines
11/20/2002EP1257578A2 Transporters and ion channels
11/20/2002EP1257559A1 Mammalian sphingosine-1-phosphate phosphatase
11/20/2002EP1257282A1 Pancreatic stem cells and their use in transplantation
11/20/2002EP1257167A1 Production of mammals which produce progeny of a single sex
11/20/2002EP0866653A4 Method of determining gender in poultry
11/20/2002CN1379977A Method for constituting clonal embryo of mammal and human clonal embryo constitution
11/19/2002US6482937 Porcine Oct-4 promoter
11/19/2002US6482929 Antibodies to ARF-p19
11/19/2002US6482624 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof
11/14/2002WO2002090567A2 Sperm-specific cation channel, and uses therefor
11/14/2002WO2002090534A1 Method for treating neurodegenerative, psychiatric and other disorders with deacetylase inhibitors
11/14/2002WO2002090532A1 Novel mutation
11/14/2002WO2002090520A2 Toll/interleukin-1 receptor adaptor protein (tirap)
11/14/2002WO2002090499A2 ss-AMYLOID PEPTIDE-BINDING PROTEINS AND POLYNUCLEOTIDES ENCODING THE SAME
11/14/2002WO2002089567A2 Sca2 knockout animal and methods of use
11/14/2002WO2002089566A1 Interstitial prostatism model animal
11/14/2002WO2002074948A3 Animal tissue with carbohydrate antigens compatible for human transplantation
11/14/2002WO2002049422A3 Non-human animal disease models
11/14/2002WO2002034890A3 Pluripotential stem cells
11/14/2002WO2002011530A9 Transgenic animal
11/14/2002WO2001035106A3 Methods for identifying and using amyloid-inhibitory compounds
11/14/2002US20020170076 Use of flp recombinase in mice
11/14/2002US20020169307 Transgenic mice containing LPR5 gene disruptions
11/14/2002US20020168781 Kit for use in the detection of pregnancy
11/14/2002US20020168753 In vitro formation of congophilic maltese-cross amyloid plaques to identify anti-plaque therapeutics for the treatment of Alzheimer's and Prion diseases
11/14/2002US20020168740 Kinase for use in the treatment of inflammation, viral infection, cancer, sepsis, psoriasis and restenosis
11/14/2002US20020168736 Nucleotide sequences coding protein for use in the treatment of immunological disorders
11/14/2002US20020168702 Isolating cells expressing secreted proteins
11/14/2002US20020168694 Maintaining stem cells of flies; obtain cells, activate signal transduction, propagate and culture cells
11/14/2002US20020168672 Nucleotide sequences coding proteins for use in the treatment of tumors
11/14/2002CA2446838A1 Novel mutation
11/14/2002CA2446640A1 .beta.-amyloid peptide-binding proteins and polynucleotides encoding the same
11/14/2002CA2446458A1 Toll/interleukin-1 receptor adaptor protein (tirap)
11/14/2002CA2445982A1 Sperm-specific cation channel, and uses therefor